What Should Specialty Pharmacists Know About the REVERCE Clinical Trial?

Kohei Shitara, MD, Department of Gastrointestinal Oncology of National Cancer Center Hospital East, Japan, discusses the importance of the REVERCE clinical trial for specialty pharmacists.

Related Videos

Related Content

Advertisement

Obesity and Metabolic Syndrome Factors Potentially Associated With Breast Cancer Receptor Subtypes, Mortality

May 17th 2024

Article

Pharmacy Focus: Oncology Edition- Integrating Oncology Pharmacists into Multidisciplinary Care Teams for Improved Patient Outcomes

March 26th 2024

Podcast

This Skin Cancer Awareness Month, Remind Patients of the Prevention Basics

May 17th 2024

Article

Pharmacy Focus: Limited Series - Celebrity Endorsements in Pharmaceuticals

February 28th 2024

Podcast

FDA Grants Accelerated Approval for Liso-Cel in Patients With Relapsed or Refractory Follicular Lymphoma

May 16th 2024

Article

Collaboration Is Key When Implementing SDOH Screening Programs

May 15th 2024

Article

Related Content

Advertisement

Obesity and Metabolic Syndrome Factors Potentially Associated With Breast Cancer Receptor Subtypes, Mortality

May 17th 2024

Article

Pharmacy Focus: Oncology Edition- Integrating Oncology Pharmacists into Multidisciplinary Care Teams for Improved Patient Outcomes

March 26th 2024

Podcast

This Skin Cancer Awareness Month, Remind Patients of the Prevention Basics

May 17th 2024

Article

Pharmacy Focus: Limited Series - Celebrity Endorsements in Pharmaceuticals

February 28th 2024

Podcast

FDA Grants Accelerated Approval for Liso-Cel in Patients With Relapsed or Refractory Follicular Lymphoma

May 16th 2024

Article

Collaboration Is Key When Implementing SDOH Screening Programs

May 15th 2024

Article